Authors:
HORVATH G
SERRU V
CLAY D
BILLARD M
BOUCHEIX C
RUBINSTEIN E
Citation: G. Horvath et al., CD19 IS LINKED TO THE INTEGRIN-ASSOCIATED TETRASPANS CD9, CD81, AND CD82, The Journal of biological chemistry, 273(46), 1998, pp. 30537-30543
Authors:
DOMBRET H
THOMAS X
BLAISE D
HUGUET F
BOIRON JM
BUZYN A
STAMATOULAS A
DELANNOY A
BRADSTOCK K
BOUCHEIX C
CHARRIN C
GABERT J
LEBBE G
LHERITIER V
FIERE D
Citation: H. Dombret et al., INTENSIVE THERAPY IN 100 PATIENTS WITH PH1 AND OR BCR-ABL POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - FIRST INTERIM ANALYSIS OF THE FRENCH-BELGIAN-AUSTRALIAN LALA-94 TRIAL/, British Journal of Haematology, 102(1), 1998, pp. 270-270
Authors:
MAYNADIE M
CAMPOS L
MOSKOVTCHENKO P
SABIDO O
AHO S
LENORMAND B
CARLI PM
GUYOTAT D
BENE MC
FAURE G
CAPIOD JC
GARDAIS J
FEUILLARD J
RAPHAEL M
LACOMBE R
LECALVEZ G
LEGLISE MC
DENEYS V
MASSON AM
BERNIER M
MALET AM
SALAUN C
BOURIN P
RAPATEL C
TAVERNIER F
JOUAULT H
LELONG F
CHRETIEN P
SOLARY E
CASASNOVAS RO
MAYNADIE M
MOSKOVTCHENKO P
FAVRE M
BENSA JC
JACOB MC
WALLEF G
SARIAUX C
TRIMOREAU F
PRALORAN V
CAMPOS L
SABIDO O
VASSELON C
BRUNET C
PONCELET P
GUITARD AM
TAIB J
LAVABREBERTRAND T
JUNG G
KANDEL G
GARAND R
PHILIP P
SUDAKA I
MONPOUX F
VANHAEKE D
PERROT JY
MARIE JP
VALENSI F
VERGE V
HOMBERG JC
SCHAISON G
BOUMSELL L
DOUAY L
SAMSON T
BRIZARD A
DALIPHARD S
DRENOU B
LEES O
LENORMAND B
POILANE B
FALKENRODT A
ALBERT A
KUHLEIN E
ESTIENNE MH
BREMOND JL
DEGENNE M
LEBARON F
REUMAUX G
DUTHILLEUL P
BENE MC
FAURE G
BORDIGONI P
WITZ F
KOLLOPSARDA MN
BAYLE C
ANTONINI J
BOUCHEIX C
CHARPENTIER A
Citation: M. Maynadie et al., HETEROGENOUS EXPRESSION OF CD15 IN ACUTE LYMPHOBLASTIC-LEUKEMIA - A STUDY OF 10 ANTI-CD15 MONOCLONAL-ANTIBODIES IN 158 PATIENTS, Leukemia & lymphoma, 25(1-2), 1997, pp. 135-143
Authors:
RUBINSTEIN E
POINDESSOUSJAZAT V
LENAOUR F
BILLARD M
BOUCHEIX C
Citation: E. Rubinstein et al., CD9, BUT NOT OTHER TETRASPANS, ASSOCIATES WITH THE BETA-1 INTEGRIN PRECURSOR, European Journal of Immunology, 27(8), 1997, pp. 1919-1927
Authors:
LAGAUDRIEREGESBERT C
LENAOUR F
LEBELBINAY S
BILLARD M
LEMICHEZ E
BOQUET P
BOUCHEIX C
CONJEAUD H
RUBINSTEIN E
Citation: C. Lagaudrieregesbert et al., FUNCTIONAL-ANALYSIS OF 4 TETRASPANS, CD9, CD53, CD81, AND CD82, SUGGESTS A COMMON ROLE IN COSTIMULATION, CELL-ADHESION, AND MIGRATION - ONLY CD9 UP-REGULATES HB-EGF ACTIVITY, Cellular immunology, 182(2), 1997, pp. 105-112
Authors:
LENAOUR F
PRENANT M
FRANCASTEL C
RUBINSTEIN E
UZAN G
BOUCHEIX C
Citation: F. Lenaour et al., TRANSCRIPTIONAL REGULATION OF THE HUMAN CD9 GENE - CHARACTERIZATION OF THE 5'-FLANKING REGION, Oncogene, 13(3), 1996, pp. 481-486
Authors:
RUBINSTEIN E
LENAOUR F
LAGAUDRIEREGESBERT C
BILLARD M
CONJEAUD H
BOUCHEIX C
Citation: E. Rubinstein et al., CD9, CD63, CD81, AND CD82 ARE COMPONENTS OF A SURFACE TETRASPAN NETWORK CONNECTED TO HLA-DR AND VLA INTEGRINS, European Journal of Immunology, 26(11), 1996, pp. 2657-2665
Authors:
DOMBRET H
GABERT J
MACINTYRE E
CAYUELA JM
CHARRIN C
THOMAS X
STOPPA AM
VEIL A
TILLY H
REIFFERS J
ATTAL M
DELANNOY A
BOUCHEIX C
RACADOT E
MICLEA JM
BLAISE D
VERNANT JP
LHERITIER V
FIERE D
Citation: H. Dombret et al., 26 PERCENT OF ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) ENROLLED IN A MULTICENTER TRIAL HAVE BCR-ABL LEUKEMIA AND HALF OF THEMCAN RECEIVE A STEM-CELL TRANSPLANTATION (SCT), Blood, 88(10), 1996, pp. 1480-1480
Authors:
RUBINSTEIN E
BOUCHEIX C
WORTHINGTON RE
CARROLL RC
Citation: E. Rubinstein et al., ANTIPLATETLET ANTIBODY INTERACTIONS WITH FC-GAMMA RECEPTOR, Seminars in thrombosis and hemostasis, 21(1), 1995, pp. 10-22
Authors:
HAOUAS H
MORELLO D
LAVENU A
BILLARD M
JASMIN C
BOUCHEIX C
Citation: H. Haouas et al., CHARACTERIZATION OF THE 5' REGION OF THE CD10 NEUTRAL ENDOPEPTIDASE-24.11 GENE, Biochemical and biophysical research communications, 207(3), 1995, pp. 933-942
Authors:
RACADOT E
SEBBAN C
BOUCHEIX C
DAVID B
ATTAL M
REIFFERS J
GISSELBRECHT C
VERNANT J
TROUSSARD X
HERVE P
FIERE D
Citation: E. Racadot et al., AUTOLOGOUS BMT FOR POSTREMISSION THERAPY IN ADULT ALL - AN IMMUNOLOGICAL APPROACH, Leukemia & lymphoma, 13, 1994, pp. 95-98
Authors:
KRIEF P
AUGERYBOURGET Y
PLAISANCE S
MERCK MF
ASSIER E
TANCHOU V
BILLARD M
BOUCHEIX C
JASMIN C
AZZARONE B
Citation: P. Krief et al., A NEW CYTOKINE (IK) DOWN-REGULATING HLA CLASS-II - MONOCLONAL-ANTIBODIES, CLONING AND CHROMOSOME LOCALIZATION, Oncogene, 9(12), 1994, pp. 3449-3456
Authors:
FEMENIA F
CRESPEAU F
FONTAINE JJ
BOUCHEIX C
PARODI AL
Citation: F. Femenia et al., EARLY HEMATOLOGICAL AND PATHOLOGICAL ABNORMALITIES OF PATHOGEN-FREE CATS EXPERIMENTALLY INFECTED WITH FELINE IMMUNODEFICIENCY VIRUS (FIV), Veterinary research, 25(6), 1994, pp. 544-554
Authors:
RUBINSTEIN E
LENAOUR F
BILLARD M
PRENANT M
BOUCHEIX C
Citation: E. Rubinstein et al., CD9 ANTIGEN IS AN ACCESSORY SUBUNIT OF THE VLA INTEGRIN COMPLEXES, European Journal of Immunology, 24(12), 1994, pp. 3005-3013
Authors:
BOUCHEIX C
DAVID B
SEBBAN C
RACADOT E
BENE MC
BERNARD A
CAMPOS L
JOUAULT H
SIGAUX F
LEPAGE E
HERVE P
FIERE D
Citation: C. Boucheix et al., IMMUNOPHENOTYPE OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA, CLINICAL-PARAMETERS, AND OUTCOME - AN ANALYSIS OF A PROSPECTIVE TRIAL INCLUDING 562 TESTED PATIENTS (LALA87), Blood, 84(5), 1994, pp. 1603-1612
Authors:
FIERE D
SEBBAN C
VERNANT JP
WITZ F
RIGALHUGUET F
BOUCHEIX C
RACADOT E
PIGNON B
DELANNOY A
REIFFERS J
SUTTON L
ARCHIMBAUD E
LEPAGE E
Citation: D. Fiere et al., LONG-TERM RESULTS OF CHEMOTHERAPY, ALLOGENEIC OR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (BMT) AS POST REMISSION THERAPY IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) FOR PATIENTS INCLUDED IN A PROSPECTIVE MULTICENTRIC TRIAL (LALA-87), Blood, 84(10), 1994, pp. 10000251-10000251
Authors:
FIERE D
LEPAGE E
SEBBAN C
BOUCHEIX C
GISSELBRECHT C
VERNANT JP
VARET B
BROUSTET A
CAHN JY
RIGALHUGUET F
WITZ F
MICHAUX JL
MICHALLET M
REIFFERS J
Citation: D. Fiere et al., ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A MULTICENTRIC RANDOMIZED TRIAL TESTING BONE-MARROW TRANSPLANTATION AS POSTREMISSION THERAPY, Journal of clinical oncology, 11(10), 1993, pp. 1990-2001